AU2004264722A1 - Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxigenase-1 - Google Patents

Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxigenase-1 Download PDF

Info

Publication number
AU2004264722A1
AU2004264722A1 AU2004264722A AU2004264722A AU2004264722A1 AU 2004264722 A1 AU2004264722 A1 AU 2004264722A1 AU 2004264722 A AU2004264722 A AU 2004264722A AU 2004264722 A AU2004264722 A AU 2004264722A AU 2004264722 A1 AU2004264722 A1 AU 2004264722A1
Authority
AU
Australia
Prior art keywords
thromboxane
receptor antagonist
cox
inhibitor
condition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004264722A
Other languages
English (en)
Inventor
Hans R. Brunner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
B M R A Corp BV
Original Assignee
BMRA Corp BV
B M R A Corp BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BMRA Corp BV, B M R A Corp BV filed Critical BMRA Corp BV
Publication of AU2004264722A1 publication Critical patent/AU2004264722A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2004264722A 2003-08-07 2004-08-05 Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxigenase-1 Abandoned AU2004264722A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49297503P 2003-08-07 2003-08-07
US60/492,975 2003-08-07
PCT/IB2004/002523 WO2005016334A1 (en) 2003-08-07 2004-08-05 Compositions and methods involving the combination of a thromboxane a2 receptor antagonist and an inhibitor of cyclooxigenase-1

Publications (1)

Publication Number Publication Date
AU2004264722A1 true AU2004264722A1 (en) 2005-02-24

Family

ID=34193159

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004264722A Abandoned AU2004264722A1 (en) 2003-08-07 2004-08-05 Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxigenase-1

Country Status (6)

Country Link
US (1) US20050059741A1 (https=)
EP (1) EP1660076A1 (https=)
JP (1) JP2007508242A (https=)
AU (1) AU2004264722A1 (https=)
CA (1) CA2534316A1 (https=)
WO (1) WO2005016334A1 (https=)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK471479A (da) * 1978-12-13 1980-06-14 Pfizer Fremgangsmaade til fremstilling af imidazolderivater og salte deraf
US5100889A (en) * 1989-04-03 1992-03-31 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
ZA911453B (en) * 1990-03-19 1991-11-27 Squibb & Sons Inc Method of protecting against and/or treating ulcerative gastrointestinal conditions using a thromoboxane,a2 receptor antagonist and combination useful in preventing and/or treating ulcers and/or inflammation
GB9220137D0 (en) * 1992-09-23 1992-11-04 Pfizer Ltd Therapeutic agents
JPH0753505A (ja) * 1992-10-01 1995-02-28 Hokuriku Seiyaku Co Ltd ベンゼンスルホンアミド誘導体及びその用途
US5605917A (en) * 1994-12-22 1997-02-25 Bristol-Myers Squibb Company Method of treating dysmenorrhea employing an interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analog
US5872145A (en) * 1996-08-16 1999-02-16 Pozen, Inc. Formulation of 5-HT agonist and NSAID for treatment of migraine
US6586458B1 (en) * 1996-08-16 2003-07-01 Pozen Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6077539A (en) * 1996-11-12 2000-06-20 Pozen, Inc. Treatment of migraine headache
AU2890899A (en) * 1998-03-13 1999-09-27 Pozen, Inc. Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists
AU2001264729A1 (en) * 2000-05-22 2001-12-03 Nitromed, Inc. Thromboxane inhibitors, compositions and methods of use related applications
SI1429807T1 (sl) * 2001-09-19 2007-08-31 Nycomed Gmbh Kombinacija NSAID in PDE-4 inhibitorja
CN1665538A (zh) * 2002-07-09 2005-09-07 B·M·R·A·有限公司 血栓烷a2受体拮抗剂和cox－2抑制剂的药物组合

Also Published As

Publication number Publication date
JP2007508242A (ja) 2007-04-05
EP1660076A1 (en) 2006-05-31
WO2005016334A1 (en) 2005-02-24
CA2534316A1 (en) 2005-02-24
US20050059741A1 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
US20080113973A1 (en) Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-2
CA2260943C (en) Formulation of 5-ht agonists
JPH07206712A (ja) ＨＭＧＣｏＡレダクターゼインヒビターを用いる心臓血管の疾患の発生の危険を予防または減少する方法
FR2559061A1 (fr) Compositions analgesiques et anti-inflammatoires contenant de la diphenhydramine
FR2530469A1 (fr) Composition analgesique et anti-inflammatoire contenant de la cafeine
FR2530468A1 (fr) Composition analgesique et anti-inflammatoire contenant de l'ibuprofen
WO2013083286A1 (en) TREATMENT OF ARTERIAL WALL BY COMBINATION OF RAAS INHIBITOR AND HMG-CoA REDUCTASE INHIBITOR
JP2017533956A (ja) 筋肉痛を含む病態の治療のための組合せ
OA11787A (en) Method for preventing or delaying catheter-based revascularization.
US4599359A (en) Hydroxyzine-containing analgesic combinations
US4794112A (en) Acetaminophen/hydroxyzine analgesic combinations
US6890941B1 (en) Compositions containing HMG Co-A reductase inhibitors and policosanol
EP0111456B1 (en) Analgesic combinations
US20050059741A1 (en) Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-1
US20110034424A1 (en) Method for the long term nsaid use
JP2011525479A (ja) 非ステロイド性抗炎症性化合物と降圧化合物とを組み合わせた製剤処方及びその使用方法
AU2004298351A1 (en) Use of stating for the treatment of metabolic syndrome
EP2680838A1 (en) TREATMENT OF ARTERIAL AGEING BY COMBINATION OF RAAS INHIBITOR AND HMG-CoA REDUCTASE INHIBITOR
AU6219799A (en) Pharmaceutical combination of ibuprofen-lysine and domperidone for treating migraine
ZA200207701B (en) Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug.
JP2011032262A (ja) Ｎｓａｉｄの長期使用のための医薬組成物
HK1080750A (en) Pharmaceutical combination of a thromboxane a2 receptor antagonist and a cox-2 inhibitor
UA146735U (uk) Фармацевтичний препарат для лікування болю та запалення
WO2012041258A1 (en) Compositions and methods for treating hypertension using eprosartan and amlodipine
WO2012116997A1 (en) TREATMENT OF ARTERIAL AGEING BY HMG CoA REDUCTASE INHIBITOR

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted